Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ABBV AbbVie
146.280-1.120-0.76%
Close
01/27 16:00 ET
146.400+0.120+0.08%
Post Mkt Price 01/27 19:05 ET
High
147.680
Open
147.310
Turnover
673.08M
Low
146.015
Pre Close
147.400
Volume
4.59M
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Income Investing: How to Play Corporate Bonds As Defaults Threaten to Bite -- Barron's
By Lawrence C. Strauss The bond market is sending mixed messages. Credit spreads -- the difference in yields between corporate debt and Treasuries -- have tightened. That's a sign of strong demand
FY2022 EPS Estimates for AbbVie Inc. Cut by Analyst (NYSE:ABBV)
AbbVie Inc. (NYSE:ABBV – Get Rating) – SVB Leerink decreased their FY2022 earnings per share (EPS) estimates for AbbVie in a report released on Wednesday, January 25th. SVB Leerink analyst D. Risi
Mount Yale Investment Advisors LLC Reduces Stock Holdings in AbbVie Inc. (NYSE:ABBV)
Mount Yale Investment Advisors LLC cut its holdings in AbbVie Inc. (NYSE:ABBV – Get Rating) by 26.4% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Co
Samson Rock Capital LLP Takes $266,000 Position in AbbVie Inc. (NYSE:ABBV)
Samson Rock Capital LLP bought a new position in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) during the third quarter, according to its most recent disclosure with the Securities and Exchange Com
AbbVie Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of AbbVie Inc. (ABBV) dropped 0.76% to $146.28 Friday, on what proved to be an all-around grea
CNBC Halftime Report Final Trades: S&P Global, General Motors & AbbVie
CNBC Halftime Report Final Trades: S&P Global, General Motors & AbbVie
5 Cheapest Health Care Stocks You Should Think About
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go
J&J Pulls Imbruvica Combo Filing in EU as EMA Cites Potential 'Serious Side Effects'
Lipid Based Formulations Global Market Report 2023: Featuring Novartis, AbbVie, F. Hoffmann-La Roche, Johnson & Johnson, Alnylam Pharmaceuticals & More
DUBLIN, Jan. 27, 2023 /PRNewswire/ -- The "Lipid Based Formulations Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027 Segmented By Source of Lipids (Natural v/s Chemically
Stick With Quality Corporate Bonds as High-Yield Defaults Start to Bite -- Barrons.com
By Lawrence C. Strauss The bond market is sending mixed messages. Credit spreads -- the difference in yields between corporate debt and Treasuries -- have tightened. That's a sign of strong demand
Company Overview
More
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
CEO： Mr. Richard A. Gonzalez
Market： NYSE
Listing Date： 12/10/2012
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet